Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Inturrisi

Showing results (31-40 of 152) with videos related to

Pageof 16
Sort By:
Annals of the New York Academy of Sciences|January 1, 1974
Ouabain sensitivity of the Na+, K+-ATPase from rat neonatal and human fetal and adult heartC E Inturrisi, M C Papaconstantinou
Journal of Chromatography|November 13, 1974
The quantitation of cyclazocine and its metabolites in human urine by use of gas-liquid chromatographyR F Kaiko, C E Inturrisi
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1976
The urinary excretion profiles of naltrexone in man, monkey, rabbit, and ratH E Dayton, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614P J Tiseo, C E Inturrisi
Clinical Pharmacology and Therapeutics|July 1, 1975
Disposition of acetylmethadol in relation to pharmacologic actionR F Kaiko, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Antinociceptive activity and toxicity of meperidine and normeperidine in miceJ G Umans, C E Inturrisi
European Journal of Clinical Pharmacology|January 1, 1985
D-Propoxyphene: accumulation or altered kinetics?W A Colburn, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1981
Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in miceJ G Umans, C E Inturrisi
Experientia|July 15, 1983
Beta-endorphin immunoreactivity in the plasma of patients with the Prader-Labhart-Willi syndrome and their normal siblingsD L Margules, C E Inturrisi
Life Sciences|January 1, 1988
Modification of the response to opioid and nonopioid drugs by chronic opioid antagonist treatmentB C Yoburn, C E Inturrisi
Pageof 16

Showing results (31-40 of 152) with videos related to

Sort By:
Pageof 16
Annals of the New York Academy of Sciences|January 1, 1974
Ouabain sensitivity of the Na+, K+-ATPase from rat neonatal and human fetal and adult heartC E Inturrisi, M C Papaconstantinou
Journal of Chromatography|November 13, 1974
The quantitation of cyclazocine and its metabolites in human urine by use of gas-liquid chromatographyR F Kaiko, C E Inturrisi
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1976
The urinary excretion profiles of naltrexone in man, monkey, rabbit, and ratH E Dayton, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614P J Tiseo, C E Inturrisi
Clinical Pharmacology and Therapeutics|July 1, 1975
Disposition of acetylmethadol in relation to pharmacologic actionR F Kaiko, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Antinociceptive activity and toxicity of meperidine and normeperidine in miceJ G Umans, C E Inturrisi
European Journal of Clinical Pharmacology|January 1, 1985
D-Propoxyphene: accumulation or altered kinetics?W A Colburn, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1981
Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in miceJ G Umans, C E Inturrisi
Experientia|July 15, 1983
Beta-endorphin immunoreactivity in the plasma of patients with the Prader-Labhart-Willi syndrome and their normal siblingsD L Margules, C E Inturrisi
Life Sciences|January 1, 1988
Modification of the response to opioid and nonopioid drugs by chronic opioid antagonist treatmentB C Yoburn, C E Inturrisi
Pageof 16